Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial

Article

Abstract: To date there are no approved antiviral drugs for the treatment of Ebola virus disease (EVD). Based

Palabras claves:

Autores:

Bah A., Baker D.P., Barry A., Barry A.A., Beavogui A.H., Boettcher J.P., Bore J.A., Cabeza-Cabrerizo M., Camara A., Christopher H. Logue, Cone M., Duraffour S., Fish E.N., Garciá-Dorival I., Gunther S., Hinzmann J., Holm T., Kaba I., Konde M.K., Koundouno F.R., Kuisma E., Mara D., Mertens M., Michel J., Nitzsche K., Pallash E., Pintilie M., Richard A.A., Sachse A., Sow M.S., Traore F.A., Vitoriano I., Zekeng E.G.

Fuentes:

scopus